Objective: To examine the naturalistic response to and cardiovascular side effects of stimulant medication in older adults with ADHD. Methods: Electronic Health Record (EHR) data of adult patients with ADHD (≥55 years) at the specialized PsyQ outpatient clinic for adult ADHD (n = 113, 55-79 years) were collected. Response, cardiovascular status, side effects, and provided medical care before and after the first ADHD medication dose have been recorded. Results: A total of 65% of the patients reported positive response to the medication, and 42% of the patients quit their medication due to side effects or nonresponse. There was a small but significant decrease in weight and increase in heart rate before and after methylphenidate use. Conclusion: Our results indicate that the use of stimulants may be a relatively safe and effective treatment for older adults with ADHD, under the condition that the cardiovascular parameters are monitored before and during pharmacological treatment. Randomized controlled trials (RCTs) are needed to confirm these findings.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.).
2.
BiedermanJ. (1998). A 55-year-old man with attention-deficit/hyperactivity disorder. Journal of the American Medical Association, 208(12), 1086–1092.
3.
BiedermanJ.MickE.SurmanC.DoyleR.HammernessP.HarpoldT.. . . SpencerT. (2006). A randomized, placebo-controlled trial of OROS Methylphenidate in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 59(9), 829–835.
4.
Canadian ADHD Resource Alliance. (2018). Canadian ADHD Resource Alliance (CADDRA): Canadian ADHD practice guidelines. In Canadian ADHD Resource Alliance (Ed.). (4th ed.).
5.
CorteseS.AdamoN.Del GiovaneC.Mohr-JensenC.HayesA. J.CarucciS.. . . CiprianiA. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet, 5(9), 727–738.
6.
CorteseS.Moreira-MaiaC. R.St FleurD.Morcillo-PenalverC.RohdeL. A.FaraoneS. V. (2016). Association between ADHD and obesity: A systematic review and meta-analysis. American Journal of Psychiatry, 173(1), 34–43. https://doi.org/10.1176/appi.ajp.2015.15020266
7.
CostelloE. J.MustilloA.ErkanliA.KeelerG.AngoldA. (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry, 60, 837–845.
8.
da SilvaM. A.LouzaM. (2008). Case of a 67-year-old woman diagnosed with ADHD successfully treated with methylphenidate. Journal of Attention Disorders, 11(6), 623. https://doi.org/10.1177/1087054707310879
9.
DolderC. R.DavisL. N.McKinseyJ. (2010). Use of psychostimulants in patients with dementia. Annals of Pharmacotherapy, 44(10), 1624–1632. https://doi.org/10.1345/aph.1P341
10.
ErmerJ.HaffeyM. B.RichardsC.LasseterK.AdeyiB.CorcoranM.. . . MartinP. (2013). Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults. Neuropsychiatric Disease and Treatment, 9, 219–229.
11.
Guldberg-KjarT.JohanssonB. (2009). Old people reporting childhood AD/HD symptoms: Retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65–80. Nordic Journal of Psychiatry, 63(5), 375–382.
12.
HennissenL.BakkerM. J.BanaschewskiT.CarucciS.CoghillD.DanckaertsM.. . . BuitelaarJ. K. (2017). Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: A systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine. CNS Drugs, 31(3), 199–215.
13.
KesslerR. C.AdlerL.BarkleyR.BiedermanJ.ConnersC. K. O. D.. . . ZaslavskyA. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163(4), 716–723.
14.
KooijJ. J. S. (2013). Adult ADHD: Diagnostic assessment and treatment (3rd ed.). Pearson Assessment and Information.
15.
LavretskyH.ReinliebM.St CyrN.SiddarthP.ErcoliL. M.SenturkD. (2015). Citalopram, methylphenidate, or their combination in geriatric depression: A randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry, 172(6), 561–569. https://doi.org/10.1176/appi.ajp.2014.14070889
16.
LensingM. B.ZeinerP.SandvikL.OpjordsmoenS. (2015). Quality of life in adults aged 50+ with ADHD. Journal of Attention Disorders, 19(5), 405–413. https://doi.org/10.1177/1087054713480035
17.
ManorI.RozenS.ZemishlaniZ.WeizmanA.ZalsmanG. (2011). When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations. Clinical Neuropharmacology, 34(4), 148–154.
18.
MichielsenM.SemeijnE. J.ComijsH. C.Ven van deP.BeekmanA. T.DeegD. J.KooijJ. J. (2012). Prevalence of attention-deficit/hyperactivity disorder in older adults in the Netherlands. British Journal of Psychiatry, 201(4), 298–305.
19.
MickE.McManusD. D.GoldbergR. J. (2013). Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults. European Neuropsychopharmacology, 23(6), 534–541.
StandaertW.KooijJ. J.KokR. M. (2010). The treatment of ADHD in elderly [Dutch]. Psyfar, 4, 26–29.
22.
VogelS. W. N.BijlengaD.BenjaminsJ. S.BeekmanA. T. F.KooijJ. J. S.Van SomerenE. J. W. (2017). Attention deficit hyperactivity disorder symptom severity and sleep problems in adult participants of the Netherlands sleep registry. Sleep Medicine, 40, 94–102.
23.
WilensT. E.MartelonM.JoshiG.BatemanC.FriedR.PettyC.BiedermanJ. (2012). Does ADHD predict substance use disorders? A 10-year follow-up study of young adults with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 50(6), 543–553.
24.
WynchankD.Ten HaveM.BijlengaD.PenninxB. W.BeekmanA. T.LamersF.. . . KooijJ. J. S. (2018). The association between insomnia and sleep duration in adults with attention-deficit hyperactivity disorder: Results from a general population study. Journal of Clinical Sleep Medicine, 14(3), 349–357.
